Literature DB >> 18573249

Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse.

Wei Ni1, Huawei Zhou, Jessica Diaz, Dennis L Murphy, Joseph R Haywood, Stephanie W Watts.   

Abstract

We hypothesized that lack of a functional serotonin transporter (SERT) would increase basal blood pressure and enhance the development of deoxycorticosterone acetate (DOCA)-salt hypertension compared to wild type (WT) controls. Mean arterial blood pressure was measured in WT and SERT knockout (KO) mice and rat models through radiotelemetry. Basal blood pressures were not different between respective WT and KO. Moreover, blood pressure elevated similarly (~50 mm Hg) in all strains given DOCA and salt. Thus, the lack of functional SERT did not prevent development of DOCA-salt induced hypertension or modify basal blood pressure significantly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573249      PMCID: PMC2527649          DOI: 10.1016/j.ejphar.2008.06.012

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats.

Authors:  Wei Ni; Keith Lookingland; Stephanie W Watts
Journal:  Hypertension       Date:  2006-06-05       Impact factor: 10.190

2.  Blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter.

Authors:  Judith Homberg; Josine Mudde; Branko Braam; Bart Ellenbroek; Edwin Cuppen; Jaap A Joles
Journal:  Hypertension       Date:  2006-10-09       Impact factor: 10.190

3.  Blood pressure changes during short-term fluoxetine treatment.

Authors:  J D Amsterdam; F Garcia-Espana; J Fawcett; F M Quitkin; F W Reimherr; J F Rosenbaum; C Beasley
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

4.  Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter.

Authors:  Dong-Kyu Kim; Teresa J Tolliver; Su-Jan Huang; Bradley J Martin; Anne M Andrews; Christine Wichems; Andrew Holmes; Klaus-Peter Lesch; Dennis L Murphy
Journal:  Neuropharmacology       Date:  2005-09-23       Impact factor: 5.250

Review 5.  5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).

Authors:  Wei Ni; Stephanie W Watts
Journal:  Clin Exp Pharmacol Physiol       Date:  2006-07       Impact factor: 2.557

6.  (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.

Authors:  Wei Ni; Claudia S Wilhelm; Michael Bader; Dennis L Murphy; Keith Lookingland; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2005-05-18       Impact factor: 4.030

7.  5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.

Authors:  S W Watts; G D Fink
Journal:  Am J Physiol       Date:  1999-03

8.  Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system.

Authors:  J R Homberg; J D A Olivier; B M G Smits; J D Mul; J Mudde; M Verheul; O F M Nieuwenhuizen; A R Cools; E Ronken; T Cremers; A N M Schoffelmeer; B A Ellenbroek; E Cuppen
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

Review 9.  The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.

Authors:  John W Funder
Journal:  Am J Cardiovasc Drugs       Date:  2007       Impact factor: 3.571

10.  Plasma serotonin levels and the platelet serotonin transporter.

Authors:  B Brenner; J T Harney; B A Ahmed; B C Jeffus; R Unal; J L Mehta; F Kilic
Journal:  J Neurochem       Date:  2007-05-15       Impact factor: 5.372

View more
  1 in total

1.  Effect of mineralocorticoid treatment in mice with collecting duct-specific knockout of endothelin-1.

Authors:  I Jeanette Lynch; Amanda K Welch; Michelle L Gumz; Donald E Kohan; Brian D Cain; Charles S Wingo
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.